Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
EFSA Journal
What they found: Mean weight loss: 2.6 kg vs 2.3 kg placebo , a difference of only 0.3 kg (1 %) Statistically non-significant Clinically unsatisfactory for the obesity indication Safety profile remained favorable Why it matters: The study stopped the development of AOD-9604 as a drug
It can reduce the risk of cardiovascular issues like heart disease and strokes in humans
For adults in the UK, the standard dietary reference intake is 1.5 micrograms (g) daily for maintenance of normal health
In contrast, intramuscular delivery achieves Tmax values of 1545 minutes for most research peptides
US$ 21.50
US$ 26.01
US$ 23.27
